Parham Academy LLC
European Academy of Biomedical Sciences


Our news & hot issues


ISI Impact factor= 5.49 (Q1)



(Reverse chronological order)

Molecular modelling, molecular dynamics simulations and in vitro evaluation of Berberine as an inhibitor of MAP kinase and PI3K pathway. (2017: Accepted as Poster presentation; Role: presenter; Poster Session Title: Experimental/Molecular Therapeutics, Pharmacogenesis I), In: "EACR-AACR-SIC Special Conference 2017: The Challenges of Optimising Immuno and Targeted Therapies: From Cancer Biology to the Clinic", 25th June, Florence, Italy.

Molecular modelling of berberine derivatives as inhibitors of smoothened receptor using a new drug discovery script for a large numbers of compounds. (2017: Poster presentation; Role: presenter; Poster Session Title: Experimental/Molecular Therapeutics, Pharmacogenesis I), In: "EACR-AACR-SIC Special Conference 2017: The Challenges of Optimising Immuno and Targeted Therapies: From Cancer Biology to the Clinic", 25th June, Florence, Italy.

Is it the right way to use intercalating agents as inhibitors of MAP kinase pathway? A challenging issue using berberine with dual cellular functionality applied in breast cancer cell models. (2017: Poster presentation; Role: presenter), In: "Tumour Microenvironment – Basic Science to Novel Therapies", 15th June 2017, Nottingham, UK.

Molecular modelling and molecular dynamics simulations of a new berberine derivative as a dual RAF inhibitor for treatment of drug resistance acquired in melanoma. (2016: Oral presentation; Role: Presenter), In: "Pharmacology", British Pharmacological Society, 13th December, London, UK. (Abstract)

Tissue regeneration in mammals: Role of Oct4 gene expression in treatment of infectious diseases. (2010: Poster presentation; Role: Presenter) "10th International MEEGID Conference (Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases)", Nov. 2010, Amsterdam, Netherlands (Elsevier).

A new cell line detected in mouse: A novel theory of stem cell applications in tissue regeneration. (2010: Oral presentation; Role: Presenter) "11th Iranian Genetics Congress", Shahid Beheshti University, May. 2010, Tehran.
ASPET annual meeting




Author watson Home 15:42:17 | | | printer friendly | | create pdf of this news item


Our article: Therapeutic miRNAs


 Pharmacological Research




Headlines





Date published: not known
Details

»The flight of the narwhal
»Gaining a foothold on kidney disease?
»Conditions in a black hole outburst
»Watching electrons lose steam in graphene
»FAK directs tumor immune evasion
»Understanding splicing from the 3' end
»A sweet source to make acrylonitrile
»One cause of accidental deaths
»Taking a direct route to the brain
»The peopling of Asia


Date published: not known
Details

»Relationship between DNA Methylation in the 5' CpG Island of the SLC47A1 (Multidrug and Toxin Extrusion Protein MATE1) Gene and Interindividual Variability in MATE1 Expression in the Human Liver [Articles]
Multidrug and toxin extrusion protein 1 (MATE1), which is encoded by solute carrier 47A1 (SLC47A1), ...
»Desensitization and Tolerance of Mu Opioid Receptors on Pontine Kölliker-Fuse Neurons [Articles]
Acute desensitization of mu opioid receptors is thought to be an initial step in the development of ...
»The X-Ray Crystal Structure of the Human Mono-Oxygenase Cytochrome P450 3A5-Ritonavir Complex Reveals Active Site Differences between P450s 3A4 and 3A5 [Articles]
The contributions of cytochrome P450 3A5 to the metabolic clearance of marketed drugs is unclear, b ...
»Evaluation of the Selectivity and Cysteine Dependence of Inhibitors across the Regulator of G Protein-Signaling Family [Articles]
Since their discovery more than 20 years ago, regulators of G protein–signaling (RGS) protein ...


Date published: not known
Details

»Correction: Identifying influential neighbors in animal flocking
»Stabilizing patterns in time: Neural network approach
»Non-linear auto-regressive models for cross-frequency coupling in neural time series
»Thalamocortical control of propofol phase-amplitude coupling
»Predicting the pathogenicity of novel variants in mitochondrial tRNA with MitoTIP
»A cyber-linked undergraduate research experience in computational biomolecular structure prediction and design
»Ten simple rules for international short-term research stays
»Automated classification of dolphin echolocation click types from the Gulf of Mexico
»Correction: Signatures of criticality arise from random subsampling in simple population models
»pSSAlib: The partial-propensity stochastic chemical network simulator
»Efficient encoding of motion is mediated by gap junctions in the fly visual system
»A model of the onset of the senescence associated secretory phenotype after DNA damage induced senescence


Date published: not known
Details


THE FOUNDER and CEO

Parham Jabbarzadeh Kaboli, PhD

Research scientist
in molecular medicine


Expert in:

Cell and molecular Biology
Modelling and drug discovery
Cancer signaling pathways

H-index= 3 (Google Scholar)
i10-index= 3
Overall ISI impact factor= 18.15
Overall citation= 110 (Google Scholar)

Memberships:

The American Society for Pharmacology and Experimental Therapeutics (ASPET)

American Association for Cancer Research (AACR)

European Association for Cancer Research (EACR)

American Association for Advancement of Science (AAAS)



CONTACT INFORMATION


Affiliation:
Department of Biomedical Science,
Faculty of Medicine and Health Sciences,
Universiti Putra Malaysia,
UPM Serdang 43400,
Selangor, Malaysia

E-Mail: parham@gromacs.net
Telegram: telegram.me/parhamacademy
Featured Publication





View the full list.
Archives

Welcome

Username:

Password:



[ ]







This site is powered by Parham Academy.
This site is powered by Parham Academy.
Render time: 0.1620 sec, 0.0519 of that for queries.